SCHEMBL4864095

SCHEMBL4864095

N#Cc1ccc(OCCCC(O)CC(=O)O)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP13 P45452 3/20 0.58
MMP12 P39900 3/20 0.58
MMP2 P08253 5/20 0.56
ALDH1A1 P00352 2/20 0.50
MAPT P10636 2/20 0.50
MMP3 P08254 5/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
POLB P06746 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
HDAC1 Q13547 1/20 0.46
HDAC2 Q92769 1/20 0.46
MMP1 P03956 1/20 0.46
MMP9 P14780 1/20 0.46
PPARD Q03181 1/20 0.44
PPARA Q07869 1/20 0.44
FNTA P49354 1/20 0.43
FNTB P49356 1/20 0.43
PARP15 Q460N3 1/20 0.42
PARP10 Q53GL7 1/20 0.42
PARP2 Q9UGN5 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL667374 0.93 MMP13 (0.59) MMP13MMP12MMP2ALDH1A1MAPT
SCHEMBL6230296 0.93 MMP13 (0.59) MMP13MMP12MMP2ALDH1A1MAPT
SCHEMBL4748763 0.83 ALDH1A1 (0.55) MMP13MMP12MMP2ALDH1A1MAPT
SCHEMBL667010 0.83 ALDH1A1 (0.55) MMP13MMP12MMP2ALDH1A1MAPT
SCHEMBL1139604 0.83 TDP1 (0.54) MMP13MMP12MMP2ALDH1A1L3MBTL1
SCHEMBL1067167 0.78 KCNA3 (0.53) MMP13MMP12MMP2L3MBTL1POLB
SCHEMBL5727733 0.78 MMP12 (0.57) MMP13MMP12L3MBTL1POLBTDP1
SCHEMBL4654973 0.78 MMP2 (0.76) MMP13MMP2ALDH1A1MAPTMMP3
SCHEMBL7514008 0.78 MMP2 (0.66) MMP13MMP2ALDH1A1MAPTMMP3
SCHEMBL4864396 0.77 MAPT (0.54) ALDH1A1MAPTL3MBTL1TDP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7425432-B2 Polyhydroxy alkanoate copolymer including within molecule unit having vinyl group or carboxyl group in side chain, and producing method therefor CANON KABUSHIKI KAISHA (JP) 2008-09-16 US disclosed
EP-1262508-B1 Novel polyhydroxyalkanoate that comprises unit having substituted (phenylmethyl) sulfanyl structure in side chain thereof and process for producing the same CANON KK (JP) 2007-08-08 EP disclosed
EP-1253475-B1 Electrostatic charge image developing toner, producing method therefor, and image forming method and image forming apparatus utilizing the toner CANON KK (JP) 2007-08-08 EP disclosed
EP-1236752-B1 Polyhydroxyalkanoate polyester having vinyl phenyl structure in the side chain and its production method CANON KK (JP) 2007-01-03 EP disclosed
US-7153622-B2 Polyhydroxyalkanate overcoating a coloring agent CANON KABUSHIKI KAISHA (JP) 2006-12-26 US disclosed
US-7135540-B2 Polyhydroxyalkanoate copolymer including unit having bromo group in side chain and method for producing the same CANON KABUSHIKI KAISHA (JP) 2006-11-14 US disclosed
US-20060211100-A1 Novel polyhydroxy alkanoate copolymer including within molecule unit having vinyl group or carboxyl group in side chain, and producing method therefor CANON KABUSHIKI KAISHA (JP) 2006-09-21 US disclosed
EP-1275727-B1 Polyhydroxyalkanoate with (methylsulfanyl) phenoxy structure in side chain CANON KK (JP) 2006-04-05 EP disclosed
US-20060040366-A1 New polyhydroxyalkanoate comprising unit having (phenylmethyl) oxy structure on side chain thereof, and method for producing the same CANON KABUSHIKI KAISHA (JP) 2006-02-23 US disclosed
EP-1340778-B1 Polyhydroxyalkanoates containing a vinylphenyl structure in their side chain and method of manufacturing the same CANON KK (JP) 2006-01-18 EP disclosed
US-20030096384-A1 Novel polyhydroxyalkanoate that comprises unit having substituted or unsubstituted (phenylmethyl) sulfanyl structure in side chain thereof and process for producing the same CANON KABUSHIKI KAISHA (JP) 2003-05-22 US disclosed
US-20030073804-A1 Polyhydroxyalkanoate, producing method therefor charge control agent containing such polyhydroxyalkanoate, toner containing such charge control agent and image forming method and image forming apparatus utilizing such toner CANON KABUSHIKI KAISHA (JP) 2003-04-17 US disclosed
US-20030059907-A1 Polyhydroxyalkanoate polyester having vinyl phenyl structure in the side chain and its production method CANON KABUSHIKI KAISHA (JP) 2003-03-27 US disclosed
EP-1275727-A2 Polyhydroxyalkanoate with (methylsulfanyl) phenoxy structure in side chain CANON KABUSHIKI KAISHA (JP) 2003-01-15 EP disclosed
EP-1262508-A2 Novel polyhydroxyalkanoate that comprises unit having substituted or unsubstituted (phenylmethyl) sulfanyl structure in side chain thereof and process for producing the same CANON KABUSHIKI KAISHA (JP) 2002-12-04 EP disclosed
EP-1254918-A2 Novel polyhydroxyalkanoate, producing method therefor, charge control agent containing such polyhydroxyalkanoate, toner containing such charge control agent and image forming method and image forming apparatus utilizing such toner CANON KABUSHIKI KAISHA (JP) 2002-11-06 EP disclosed
EP-1253475-A2 Electrostatic charge image developing toner, producing method therefor, and image forming method and image forming apparatus utilizing the toner CANON KABUSHIKI KAISHA (JP) 2002-10-30 EP disclosed
EP-1236752-A2 Polyhydroxyalkanoate polyester having vinyl phenyl structure in the side chain and its production method CANON KABUSHIKI KAISHA (JP) 2002-09-04 EP disclosed
US-20020081646-A1 Production method of polyhydroxyalkanoate form substituted fatty acid ester as raw material CANON KABUSHIKI KAISHA (JP) 2002-06-27 US disclosed
EP-1201763-A2 Production method of polyhydroxyalkanoate from substituted fatty acid ester as raw material CANON KABUSHIKI KAISHA (JP) 2002-05-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020081646-A1 Production method of polyhydroxyalkanoate form substituted fatty acid ester as raw material FASN, FFAR1, ACADM MMP13 1681/4885MMP12 1276/4885MMP2 1605/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.